Page 4 - Management of Advanced Urothelial Carcinoma: Emerging Therapies and Biomarkers
P. 4

Disclosure of Financial Support






                    o This program has received financial support from Janssen in

                         the form of an educational grant.


                    o The GURC consortium has received financial support from

                         Janssen.
   1   2   3   4   5   6   7   8   9